Programs affecting safety and innovation in pediatric therapies : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 22, 2007
Saved in:
Corporate Author: | United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health |
---|---|
Format: | Book |
Language: | English |
Published: |
Washington :
U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O.,
2008
|
Subjects: | |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Programs affecting safety and innovation in pediatric therapies : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 22, 2007.
Published: (2008) -
Ensuring safe medicines and medical devices for children : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session on examining ensuring safe medicines and medical devices for children, March 27, 2007.
Published: (2008) -
Discussion drafts concerning Prescription Drug User Fee Act reauthorization, Medical Device User Fee and Modernization Act reauthorization, drug safety, and certain pediatric pharmaceutical and device legislation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, June 12, 2007.
Published: (2008) -
Discussion drafts concerning Prescription Drug User Fee Act reauthorization, Medical Device User Fee and Modernization Act reauthorization, drug safety, and certain pediatric pharmaceutical and device legislation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, June 12, 2007
Published: (2008) -
Better pharmaceuticals for children : assessment and opportunities : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, first session on examining the impact of the pediatric exclusivity provision of the better pharmaceuticals for children act, which grants a pharmaceutical company an additional 6 months of market exclusivity for new or marketed drugs in exchange for conducting pediatric studies requested by the Food and Drug Administration, May 8, 2001.
Published: (2001)